Popular Articles

National Institutes Of Health Announces New Program To Develop Therapeutics For Rare And Neglected Diseases
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
generic viagra online
'Death Receptors' Designed To Kill Our Cells May Make Them Stronger
It turns out that from the perspective of cell biology, Nietzsche may have been right after all: that which does not kill us does make us stronger. In a review article published in the June 2009 print issue of The FASEB Journal, scientists from the Mayo Clinic explain how cell receptors (called "death receptors") used by the body to shut down old, diseased, or otherwise unwanted cells (called "apoptosis") may also be used to make cells heartier when facing a wide range of illnesses, from liver disease to cancer.
News of the day
Sacramento, Calif., Latest Site For State HIV/AIDS Budget Proposal Protests
The Los Angeles Times examined the effects of the proposed $80.1 million in budget cuts to HIV/AIDS programs in the state, as advocates are expected today to convene at the California State Capitol in Sacramento to protest the cuts. According to the Times, the proposed cuts would mean that the costs of running many HIV/AIDS-related programs would be shifted to local jurisdictions study, which "would become increasingly difficult for cash-strapped counties." HIV/AIDS programs would also need to rely more heavily on available federal financing. HIV education, prevention, counseling and testing services and early intervention programs would be affected, the Times reports. The state"s AIDS Drug Assistance Program would stand to lose $12 million (Yoshino, Los Angeles Times, 6/9). In related news, the Santa Cruz News examined how the proposed state budget cuts could put the Santa Cruz AIDS Project"s centers and programs, including sex education in schools and a needle exchange program "in serious jeopardy" (Lussenhop, Santa Cruz News, 6/9).
Diagnostics

MDA Re-Elects Three Researchers To National Leadership Roles

Three prominent figures in the field of neuromuscular disease research have been re-elected to national leadership positions with the Muscular Dystrophy Association (MDA). Stanley H. Appel of Houston, R. Rodney Howell of Miami, and Louis M. Kunkel of Boston were re-elected to one-year terms on MDA"s Board of Directors at the Association"s recent annual meeting in Los Angeles. Howell is chairman of the board. Appel is chief of neurology at The Methodist Hospital in Houston, as well as director of the MDA Neuromuscular Clinic there. He serves as chairman of MDA"s Medical Advisory Committee. A noted pediatrician, Howell is chairman emeritus and a professor at the University of Miami School of Medicine in its Department of Pediatrics. The author of more than 100 scientific articles and books, he has served on MDA"s Board since 1994 and previously chaired its Scientific Advisory Committee. Kunkel is a professor of pediatrics at Children"s Hospital Boston. He has authored dozens of scientific articles and books, and devoted more than three decades to understanding the underlying molecular bases for neuromuscular diseases. He serves as chairman of MDA"s Scientific Advisory Committee. "MDA is very fortunate to have volunteer leadership of the quality that this outstanding research trio possesses," said MDA President & CEO Gerald C. Weinberg. "Their unique skills and experience are invaluable in helping the Association achieve its goal of finding treatments and cures for devastating diseases." MDA is the nonprofit health agency dedicated to curing muscular dystrophy, ALS and related diseases by funding worldwide research. The Association also provides comprehensive health care and support services, advocacy and education. The majority of contributions to MDA come from individual donors. Muscular Dystrophy Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):